8257 — Genes Tech group Co Income Statement
0.000.00%
- HK$58.00m
- HK$159.50m
- TWD931.96m
- 31
- 92
- 28
- 51
Annual income statement for Genes Tech group Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,498 | 1,497 | 1,599 | 1,333 | 932 |
Cost of Revenue | |||||
Gross Profit | 400 | 342 | 365 | 326 | 263 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,287 | 1,367 | 1,667 | 1,188 | 822 |
Operating Profit | 211 | 131 | -68 | 145 | 110 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 197 | 118 | -82.4 | 126 | 92.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 144 | 79.4 | -80.4 | 90.6 | 24.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 144 | 79.4 | -80.4 | 90.6 | 24.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 144 | 79.4 | -80.4 | 90.6 | 24.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.139 | 0.079 | 0.087 | 0.091 | 0.012 |
Dividends per Share |